ERC-2024-POC
ERC-2024-POC
Programme: H2020
245 projects · €36,750,000 total EU contribution (project-level) · 154 participating organizations · 24 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€36,750,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (20)
- Germany (18)
- Italy (18)
- Netherlands (17)
- UK (13)
- France (12)
- AT (8)
- BE (7)
- SE (7)
- IL (6)
- IE (4)
- NO (4)
- DK (3)
- CY (2)
- FI (2)
- HR (2)
- PL (2)
- PT (2)
- TR (2)
- CH (1)
- CZ (1)
- LT (1)
- LU (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- DAY ONE9 projects · IT
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE9 projects · UK
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE8 projects · UK
- CNRS7 projects · FR
- TECHNICAL UNIVERSITY OF DENMARK DTU7 projects · DK
- MPG7 projects · DE
- THE HEBREW UNIVERSITY OF JERUSALEM6 projects · IL
- CSIC5 projects · ES
- INSERM5 projects · FR
- POLIMI5 projects · IT
- ULEI5 projects · NL
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN4 projects · DE
Projects
Page 15 of 25
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Differential Diagnosis of Autoimmune Hepatitis by cfChIP-seq Liquid Biopsy AIHLiquidBiopsy · 101189389 | HORIZON | €150,000 | €0 | Details |
Overcoming PAncreatic cancer immunotherapy resistance: developing PYRimidine receptor antagonists PA-PYR-us · 101213158 | HORIZON | €150,000 | €0 | Details |
Using senolytic agents to suppress the toxicity of chemotherapy CHEMOPROTECT · 101213120 | HORIZON | €150,000 | €0 | Details |
Nanoengineered particles for enhanced cancer radiotherapy ENCANT · 101189443 | HORIZON | €150,000 | €0 | Details |
Improving cancer therapy by identification of novel drug leads modulating transcription termination bridging molecular biology and therapeutic applications ModulatEnds · 101212992 | HORIZON | €150,000 | €0 | Details |
Explainable Anomaly Detection for Safeguarding and Enhancing Modern Data Industry ExplainableAD · 101213783 | HORIZON | €150,000 | €0 | Details |
Targeting Type 2 Diabetes with Allene-containing Molecules Using a C-N Bond Cleavage Tool ALLENEDRUG · 101213797 | HORIZON | €150,000 | €0 | Details |
PREDICT: PRoviding Effective longitudinal models of RAS DIrect inhibition to Combat Tumor resistance PREDICT · 101189458 | HORIZON | €150,000 | €0 | Details |
Integrated photonics-based structured illumination for sequencing INPHOSIS · 101213646 | HORIZON | €150,000 | €0 | Details |
Widely Tunable Soliton Microcomb Chip ELASTIC · 101213805 | HORIZON | €150,000 | €0 | Details |